Dozens of precision cancer drugs tested at lower doses to reduce side effects and cut costs
Nat Med
.
2024 Mar;30(3):611-614.
doi: 10.1038/s41591-024-02845-7.
Author
Sofia Moutinho
1
Affiliation
1
Freelance writer, Rio de Janeiro, Brazil.
PMID:
38443689
DOI:
10.1038/s41591-024-02845-7
No abstract available
Publication types
News
MeSH terms
Antineoplastic Agents* / adverse effects
Costs and Cost Analysis
Neoplasms* / drug therapy
Substances
Antineoplastic Agents